Volume 8, Number 10—October 2002
THEME ISSUE
Bioterrorism-related Anthrax
Bioterrorism-related Anthrax
Adherence to Antimicrobial Inhalational Anthrax Prophylaxis among Postal Workers, Washington, D.C., 2001
Table 4
Characteristics | Discontinued (n=45) n (%) | Full adherence (n=98), n (%) | RR (95% CI) | p value |
---|---|---|---|---|
Sexb | ||||
Female | 25 (56) | 52 (54) | 1.0 (0.7, 1.4) | n.s. |
Male | 20 (44) | 45 (46) | Ref | - |
Ageb | ||||
18–44 y | 25 (56) | 16 (16) | 3.4 (2.0, 5.7) | p<0.05 |
>45 y | 20 (44) | 81 (84) | Ref | - |
Race/ethnicityb | ||||
Black | 36 (80) | 88 (91) | 0.9 (0.7, 1.04) | n.s. |
Other | 3 (7) | 3 (3) | 2.2 (0.4, 10.4) | n.s. |
White | 6 (13) | 6 (6) | Ref | - |
Work description at interviewc | ||||
Driver | 6 (13) | 8 (8) | 1.6 (0.6, 4.4) | n.s. |
Government mail | 3 (7) | 21 (21) | 0.3 (0.1, 0.99) | p<0.05 |
Administration | 12 (27) | 6 (6) | 4.3 (1.7, 10.9) | p<0.05 |
Plant floor | 24 (53) | 63 (64) | Ref | - |
Worked on sorter or in government mail sectiond | ||||
Yes | 18 (43) | 70 (75) | 0.6 (0.4, 0.8) | p<0.05. |
No | 24 (57) | 23 (25) | Ref | - |
Perceived riske | ||||
High | 16 (35) | 60 (61) | 0.6 (0.4, 0.9) | p<0.05 |
Some | 25 (56) | 35 (36) | 1.5 (1.1, 2.2) | p<0.05 |
None | 4 (9) | 3 (3) | Ref | - |
Adverse effectsf | ||||
A lot | 11 (25) | 9 (9) | 2.7 (1.2, 6.0) | n.s. |
Some | 19 (42) | 48 (49) | 0.9 (0.6, 1.3) | n.s. |
Not at all | 15 (33) | 41 (42) | Ref | - |
Physical signs of stressg | ||||
5–11 signs | 7 (16) | 28 (29) | 0.5 (0.2, 1.1) | n.s. |
1–4 signs | 29 (64) | 57 (58) | 1.1 (0.8, 1.4) | n.s. |
0 signs | 9 (20) | 13 (13) | Ref | - |
Anxietyh | ||||
Yes | 17 (38) | 33 (34) | 1.1 (0.7, 1.8) | n.s. |
No | 28 (62) | 65 (66) | Ref | - |
Trouble remembering pillsi | ||||
Yes | 23 (51) | 44 (45) | 1.1 (0.8, 1.6) | n.s. |
No | 22 (49) | 54 (55) | Ref | - |
Worse work performancej | ||||
Yes | 9 (20) | 15 (15) | 1.3 (0.6, 2.7) | n.s. |
No | 36 (80) | 83 (85) | Ref | - |
aRR, relative risk; 95% CI, 95% confidence interval; n.s., not statistically significant.
bOne missing value for full adherence.
cWork location during the survey interview, December 18–20, 2001.
dWorked close to these areas for more than half of the normal workdays during exposure period of October 12–21, 2001. Responses of “don’t know” excluded from analysis (n=13).
ePerceived risk of breathing in Bacillus anthracis spores during exposure period of October 12–21, 2001.
fReported how much side effects affected their lives.
gPhysical signs of stress included fatigue, headaches, chest pain, rapid heartbeat, unplanned changes in weight, less sleep or difficulty in sleeping, muscle tremors or twitches, difficulty or rapidity in breathing, elevated blood pressure, nausea or vomiting, and dizziness or lightheadedness.
hReported they experienced anxiety since anthrax events started. Anxiety was one of 22 listed physical, emotional, mental, and behavioral signs of stress on our questionnaire.
iReported they sometimes or almost always had trouble remembering their pills.
jReported side effects negatively affected their work performance.
1 The following members of the team were involved in the Washington, D.C., area response: Theodies Mitchell, Charlie Chamberlain, Arlene Shaw, Margaret Patterson, Chang Lee, Daryle Hardge, Veronica McCant, Robert Fireall, Colleen Crowley, Sandra Mattson, Margaret Tipple, Suzanne Lebovit, Pat Cook, Valerie J. Curry, Kelly Holton, Susan L. Lukacs, Julia C. Rhodes, Cindy R. Friedman, Holly A. Williams, Michelle G. Goveia, Leigh Winston, Heather Burke, Veronica Alvarez, Gail M. Stennies, Ernest E. Smith, Brigette Finkelstein, Julia Smith, Bobbie Person, Ian Williams, Wanda Walton, Nick Deluca, Regina Bess, Gabrielle Benenson, Kathleen Hutchins, and Luetta Schneider.